Nuveen Dow 30 Dynamic Overwrite Fund
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$14.10
FAIR PRICE
$7.67
MARGIN
$6.43
NOW AVAILABLE
Get notified when DIAX's fair price changes
Push notifications when DIAX's valuation shifts. Available on iOS and Android.
FPI RATING
Strong profitability and attractive valuation, but volatile earnings pattern and limited growth momentum.
Analytical data, not an investment recommendation. Updated daily.
How we calculate this ↗MARGIN OF SAFETY
A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.
SAFETY MARGIN
20%
Below fair value
ENTRY LEVEL
$6.14
Fair price × 0.80
DISTANCE
56.5%
Price to entry level
At the current price of $14.10, DIAX trades 56.5% above the conservative entry level of $6.14. This entry level represents a 20% margin of safety below the calculated fair price of $7.67 — a buffer that accounts for estimation uncertainty in the valuation model.
Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗
VALUATION HISTORY
Loading chart data...
P/E RATIO HISTORY
Loading chart data...
METHODOLOGY
How we calculate DIAX's fair price
Nuveen Dow 30 Dynamic Overwrite Fund's fair price of $7.67 is derived from a blended model that combines DCF analysis (50%), relative valuation against Financial Services peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $14.10, DIAX trades 45.6% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting DIAX's risk profile.
RELATIVE · 30%
Comparing DIAX's valuation multiples against Financial Services peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for DIAX, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate DIAX's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for DIAX.
Explore on BuliosFAQ
What is the fair price of DIAX?+
Based on our blended model combining DCF analysis (50%), relative valuation against Financial Services peers (30%), and analyst consensus (20%), the fair price for Nuveen Dow 30 Dynamic Overwrite Fund is $7.67. At the current market price of $14.10, DIAX trades 45.6% above its calculated fair value.
Is DIAX overvalued or undervalued?+
Nuveen Dow 30 Dynamic Overwrite Fund is currently overvalued based on our valuation model. The stock trades at $14.10, which is 45.6% above the fair price of $7.67. The P/E ratio of 8.4x is a key metric in the valuation.
What is the margin of safety for DIAX?+
With a 20% margin of safety applied to the fair price of $7.67, the conservative entry level for DIAX is $6.14. At the current market price of $14.10, the stock trades 56.5% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.
How often is DIAX's fair price updated?+
We update fair price calculations for DIAX daily after market close. The current fair price of $7.67 incorporates the latest market data and sector multiples.
What factors affect DIAX's fair price calculation?+
DIAX's fair price of $7.67 is derived from DCF analysis (50% weight), relative valuation against Financial Services peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 8.4x, and dividend yield of 8.54%.
Is DIAX a good buy right now?+
At $14.10, DIAX trades 45.6% above our fair value estimate of $7.67. The stock is currently overvalued. Fair Price Index provides valuation data — always do your own research before investing.
Does DIAX pay dividends?+
DIAX has a dividend yield of 8.54%.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.

